FINWIRES · TerminalLIVE
FINWIRES

Australian Services Sector Edges Back into Growth Amid Inflation Pressures, Weak Demand

By

-- Australian services activity edged back into expansion in April as firms increased hiring and output, but persistent inflation driven by higher fuel costs linked to Middle East tensions continued to weigh on new orders and keep business sentiment subdued, according to a monthly survey by S&P Global released Tuesday.

The S&P Global Australia Services PMI Business Activity Index rose to 50.7 in April from 46.3 in March, signaling a return to slight expansion after a brief contraction.

Rising staffing levels helped firms expand activity despite falling orders driven by higher Middle East war-related fuel costs, with growth limited to information and communication and consumer services, while other sectors declined, per the survey.

Business activity returned to growth in April, but new orders fell for a second consecutive month at a slightly faster pace as the Middle East conflict weighed on demand, even though export orders rebounded after a sharp decline the previous month.

Higher fuel prices pushed up input costs and accelerated inflation to its fastest pace since August 2022, with over 43% of firms reporting increases and the transport and storage sector recording the sharpest rises in both input and selling prices.

Output prices in Australia's service sector rose rapidly as fuel costs were passed through to customers, marking the fastest inflation since January 2023, while employment continued to expand for the sixteenth consecutive month at a solid pace, the survey said.

Business expansion plans lifted the 12-month outlook despite subdued sentiment, while rising employment and weaker new orders led firms to clear backlogs for a second month at the fastest pace since November 2024.

The Composite Output Index rose to 50.4 in April from 46.6 in March, moving back above the 50 no-change mark and indicating a slight recovery in business activity after the previous month's decline.

Output rose in April due to services growth while manufacturing fell, as new orders declined amid strong inflation, and input and output prices increased at their fastest pace since 2022.

Staffing levels increased strongly, exceeding the rise seen in March, while business sentiment declined further to its lowest point in 22 months, the survey added.

Related Articles

Asia

Telix Pharmaceuticals' Investigational Imaging Agent May Potentially Diagnose a Range of Kidney Cancers

Telix Pharmaceuticals' (ASX:TLX) investigational imaging agent TLX250-Px has the potential to help diagnose kidney cancers beyond just clear cell renal cell carcinoma, or ccRCC, the company said Tuesday, citing an independent analysis published in the European Urology scientific journal.The analysis of phase three trial data showed that positive PET scan findings were "highly predictive" of malignancy overall, including in non-clear cell renal cell carcinoma, with a reported positive predictive value of 98%, the company said."Essentially all false-positives for ccRCC in the ZIRCON study have now been shown to be other malignant kidney cancer subtypes, reducing the risk of overtreatment and further supporting clinical adoption," said Telix Group Chief Medical Officer David Cade.

$ASX:TLX
Asia

Huajin International Chairman, CEO Face Consumption Restriction Order

Huajin International (HKG:2738) said its chairman and chief executive were subject to a consumption restriction order due to the alleged nonpayment of amounts owed, according to a Hong Kong bourse filing Tuesday.The company's chairman Xu Songqing and chief executive Chen Chunniu have been subject to the consumption restriction order, effective Nov. 25.The case stems from the alleged non-payment of 130 million yuan by two of the company's units Jiangmen Huamu Metals and Jiangmen Huajin Metal Product, under a finance lease arrangement. As of April 30, 16.4 million yuan was still owed to the creditors.Both Xu and Chen have been negotiating with creditors to resolve the matter and the company expects to reach a settlement by the end of August.

$HKG:2738
Asia

Tata Chemicals' Consolidated Loss Widens in Fiscal Q4

Tata Chemicals' (NSE:TATACHEM, BOM:500770) consolidated attributable loss widened to 21.3 billion Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 1.56 billion rupees a year ago.Loss per share grew to 83.68 rupees compared with a loss per share of 2.19 rupees a year earlier, the chemicals manufacturer said in a filing to the Indian bourses on Monday.Revenue from operations in fiscal Q4 declined to 34.4 billion rupees from 35.1 billion rupees a year ago. This was lower than the 34.8 billion rupees estimated by analysts polled by Visible Alpha.The company's board recommended a dividend of 11 rupees per share for the financial year ended March 31.

$BOM:500770$NSE:TATACHEM